HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel beta-globin structural mutant, Hb Brescia (beta 114 Leu-Pro), causing a severe beta-thalassemia intermedia phenotype.

Abstract
This study describes a patient with a thalassemia intermedia-like phenotype in whom beta-globin gene sequencing detected a novel abnormal hemoglobin (Hb) due to a T-C substitution at codon 114 of the beta-globin gene arising as a de novo mutation. The abnormal variant was designated Hb Brescia after the place of birth of the propositus. Normal sequences were detected at the in trans beta-globin locus. In addition, alpha-globin gene analysis detected a triple alpha-globin locus which was inherited from the father. The T-C change at position 114 of the beta-globin gene results in a leucine to proline substitution (Leu-Pro) in the G-helix. The resulting Hb tetramer is highly unstable and precipitates forming inclusion bodies in the peripheral red blood cells. Moreover, the Leu-Pro substitution interferes negatively with the four alpha 1 beta 1 contact points of the G-helix most likely adversely affecting the alpha beta dimer formation. The very severe phenotype presented by our patient is unusual in a heterozygote for an unstable Hb variant and may be explained by the coinheritance of the triple alpha-globin locus.
AuthorsS Murru, D Poddie, G V Sciarratta, S Agosti, M Baffico, C Melevendi, M Pirastu, A Cao
JournalHuman mutation (Hum Mutat) Vol. 1 Issue 2 Pg. 124-8 ( 1992) ISSN: 1059-7794 [Print] United States
PMID1301199 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobins, Abnormal
  • Macromolecular Substances
  • hemoglobin Brescia
  • Globins
  • Proline
  • Leucine
Topics
  • Adolescent
  • Base Sequence
  • Erythrocytes (physiology)
  • Female
  • Globins (genetics)
  • Hemoglobins, Abnormal (genetics)
  • Humans
  • Italy
  • Leucine
  • Macromolecular Substances
  • Male
  • Molecular Sequence Data
  • Proline
  • beta-Thalassemia (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: